0
Signin
countryflagUS

18889881171

AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

Zenith Capital Corp

Healthcare US ZHCLF

0.18USD
-(-%)

Last update at 2024-05-15T16:14:00Z

Day Range

0.180.18
LowHigh

52 Week Range

0.070.30
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Income before tax - -7.76800M -6.88000M -9.57800M -11.30100M
Minority interest - - - - -
Net income - -7.79700M -6.91300M -9.63000M -11.32700M
Selling general administrative - 3.33M 2.07M 2.18M 2.79M
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation - 0.19M 0.19M 0.22M 0.29M
Ebit -11.16400M -7.37800M -6.77500M -9.35700M -11.15800M
Ebitda - -7.30700M -6.57300M -9.35100M -10.87200M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income - -7.37800M -6.67000M -10.34300M -11.15800M
Other operating expenses - - - - -
Interest expense - 0.27M 0.12M 0.01000M 0.00000M
Tax provision - 0.03M 0.03M 0.05M 0.03M
Interest income - - 0.10M - 0.01M
Net interest income - -0.50700M -0.01500M -0.11000M 0.01M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.02M 0.03M 0.03M 0.05M 0.03M
Total revenue - 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses - 7.38M 6.67M 10.34M 11.16M
Cost of revenue - - - - -
Total other income expense net - 0.12M -0.19500M 0.88M -0.15600M
Discontinued operations - - - - -
Net income from continuing ops - -7.79700M -6.91300M -9.63000M -11.32700M
Net income applicable to common shares -13.12000M -7.79700M -6.91300M -9.63000M -11.32700M
Preferred stock and other adjustments - - - - -
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Total assets - 2.88M 3.33M 3.40M 3.92M
Intangible assets - 0.88M 0.78M 0.59M 1.34M
Earning assets - - - - -
Other current assets 0.06M 0.01M 0.29M 0.05M 0.03M
Total liab - 16.72M 13.73M 14.16M 7.69M
Total stockholder equity - -13.83900M -10.39700M -10.75700M -3.77200M
Deferred long term liab 0.70M 0.71M 0.51M 0.52M 0.00600M
Other current liab 0.17M 0.08M 0.26M 1.38M 2.71M
Common stock 89.62M 80.94M 80.08M 75.64M 73.75M
Capital stock - 80.94M 80.08M 75.64M 73.75M
Retained earnings -118.36000M -105.24000M -97.44300M -90.53000M -80.90000M
Other liab 11.35M 11.35M 8.20M 7.28M -
Good will - - - - -
Other assets 0.70M 0.77M 0.55M 1.31M 0.33M
Cash - 0.00800M 0.00700M 0.21M 0.21M
Cash and equivalents - - - - -
Total current liabilities 6.68M 5.36M 5.52M 6.88M 7.69M
Current deferred revenue - - - - -
Net debt - 3.47M 2.65M 0.38M -
Short term debt - - - - -
Short long term debt - 3.48M 2.65M 0.59M -
Short long term debt total - - - - -
Other stockholder equity 2.14M 0.81M 2.31M 0.47M 0.23M
Property plant equipment 0.10M 0.22M 0.35M 0.49M 0.63M
Total current assets 1.38M 1.00M 1.64M 1.01M 1.62M
Long term investments - - - - -
Net tangible assets -15.86000M -14.72100M -11.17800M -11.34900M -5.11200M
Short term investments - - - - -
Net receivables 1.16M 0.16M 0.14M 0.09M 0.14M
Long term debt - - - - -
Inventory 0.11M 0.30M 0.63M 0.40M 0.38M
Accounts payable 2.07M 1.65M 2.29M 4.05M 4.12M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.76M 0.55M 0.82M 0.32M
Deferred long term asset charges - - - - -
Non current assets total - 1.88M 1.69M 2.40M 2.29M
Capital lease obligations - - - 0.50M 0.92M
Long term debt total - - - - -
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Investments - -0.25600M -0.24900M -0.37100M -0.35200M
Change to liabilities 0.34M 3.48M -1.78100M 6.40M 4.26M
Total cashflows from investing activities -0.17400M -0.25600M -0.24900M -0.37100M -0.35200M
Net borrowings 1.02M 0.72M 2.68M 0.59M 0.59M
Total cash from financing activities 9.28M 1.10M 7.97M 3.11M 4.91M
Change to operating activities -0.63400M 0.18M -0.61400M -0.42000M 0.30M
Net income -13.12000M -7.79700M -6.91300M -9.63000M -11.32700M
Change in cash 0.02M 0.00100M -0.20700M 0.00600M -0.95600M
Begin period cash flow 0.00800M 0.00700M 0.21M 0.21M 1.16M
End period cash flow - 0.00800M 0.00700M 0.21M 0.21M
Total cash from operating activities -9.08400M -0.84700M -7.92700M -2.73000M -5.50800M
Issuance of capital stock - 0.48M 5.45M 2.50M 4.84M
Depreciation 0.20M 0.19M 0.19M 0.21M 0.28M
Other cashflows from investing activities 0.02M -0.09400M 0.07M -0.05100M 0.08M
Dividends paid - 0.00000M 0.00000M 0.00000M -
Change to inventory 0.26M 0.30M 0.04M -0.00400M -0.32800M
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.19000M -0.13500M -0.17200M -0.02200M -0.02200M
Change to netincome 3.87M 2.79M 1.16M 0.70M 1.30M
Capital expenditures 0.00000M 0.16M 0.32M 0.01M 0.01M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - 3.97M -2.35900M 6.49M 4.24M
Stock based compensation - 2.33M 1.01M 0.55M 1.17M
Other non cash items - 0.34M 0.07M -1.37200M 0.14M
Free cash flow - -1.00900M -8.24600M -3.05000M -5.94100M

Fundamentals

  • Previous Close 0.18
  • Market Cap17.24M
  • Volume1800
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-13.37800M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.06

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
ZHCLF
Zenith Capital Corp		 - -% 0.18 - - - - -1.3156
NVO
Novo Nordisk A/S		 -1.63 1.21% 133.03 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S		 0.57 0.43% 132.69 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 1.20 0.27% 438.69 30.40 24.75 10.68 6.25 9.52 20.36
CSLLY
CSL Ltd		 1.03 1.09% 96.00 42.45 26.95 7.05 5.80 7.85 26.51

Reports Covered

Stock Research & News

View All

Profile

Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. Its lead compound ZEN-3694, which is in Phase 2 clinical trial for the treatment of metastatic castration resistant prostate cancer, as well as advanced or metastatic triple negative breast cancer in collaboration with Pfizer Inc. The company has research and development collaboration agreement with National Cancer Institute, and licensing agreement with Newsoara to develop ZEN-3694, as well as with University of California. The company was formerly known as Zenith Epigenetics Corp. and changed its name to Zenith Capital Corp. in August 2016. The company was incorporated in 2013 and is headquartered in Calgary, Canada.

Zenith Capital Corp

4820 Richard Road SW, Calgary, AB, Canada, T3E 6L1

Key Executives

Name Title Year Born
Mr. Donald J. McCaffrey Chairman, Pres & CEO NA
Mr. Aaron Bradley Cann C.A., CPA, CA, CPA, CBV CFO & Sec. NA
Dr. Sanjay Lakhotia M.B.A., Ph.D. Chief Bus. Officer NA
Dr. Henrik Claus Hansen Ph.D. Sr. VP of Operations NA
Dr. Huan Zhu Chief Medical Officer NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).